Comment Re:But (Score 1) 22
rfc 9309 was formally standardized and published in Sept of 2022.
There was not a SINGLE story I can find that was written about it at that time.
Field vs Google: Yes it was used, but it was a fairly niche ruling. It was not a ruling that every missing robots.txt file grants unlimited permission to scrape. From what (IANAL) i understand, the result rested on unusually very specific facts: Field understood Google’s system, intentionally allowed caching and later tried to sue over the predictable result.
One of the more interesting bits in the standard is that RFC 9309 itself says robots.txt rules “are not a form of access authorization."
Comment Re:But (Score 1) 22
Comment Re:And not body thought to use the ADOBE word? (Score 1) 58
Comment And not body thought to use the ADOBE word? (Score 0) 58
Comment Did Apple send in Double Agents? Lines Crossed? (Score -1, Flamebait) 50
Comment All caused by CFS Syndrome (Score 3, Interesting) 27
Comment 1000 CD's - so that is like what 20% of WIn11? (Score 1) 67
Comment GLP1 - The Ozempic Effect (Score 3, Interesting) 132
While clearly awesome for weight loss, much of the "beyond" benefit is still being untangled as either a direct drug effect versus downstream consequence of the weight loss and metabolic improvement itself. Many clinicians describe seeing improvement across cardiovascular and metabolic comorbidities "probably due to both weight loss and direct effect of the medication. Most of the newer findings are associational, not proven cause-and-effect.
- Slowing Biological Aging: A landmark June 2026 study published by the U of Cali found that semaglutide slowed the pace of biological aging by roughly 9%. This is driven by reductions in chronic immune activation and metabolic stress
- Type 2 Diabetes - a 2% A1C reduction and 16.8% weight loss.
- Liver: Semaglutide outperformed placebo in treating advanced fatty liver disease (MASH/MASLD) in a trial
- Cardiovascular Health - cardioprotective effects independent of weight loss,
- Improved cholesterol, blood pressure, and inflammation metrics
- Brain Health - Neuroprotection: Animal studies suggest semaglutide may counteract memory loss associated with Alzheimer's disease by reducing brain inflammatio
- Pain & Motivation: A mouse study showed GLP-1s can ease pain and reduce the motivation to exercise (studies underway)
- Addiction: Early studies suggest GLP-1s may help reduce cravings for substances like alcohol and nicotine
- Sleep Apnea: Tirzepatide was approved in 2024 to treat obstructive sleep apnea
- Bone: Evidence is mixed-some studies show neutral effects, while others suggest glp1s may enhance bone formation in certain populations
- again Immune System: They exert broad antiinflammatory effects that reduce the risk of secondary infections and inflammation-driven conditions, such as sepsis and cellulitis.
With estimated 50million US having been on GLp1's in the last 5 years, that more than accounts for the bump in life expectancy.
Comment Re:Innovation (Score 1) 88
Comment Long time Opera user - Vivalidi is Cool (Score 1) 31
Comment Search box is now the Slop Box (Score 5, Informative) 79
Comment No serious programmer every used it (Score 2) 82
Comment Browse Forest Browse Stupid is as stupid does (Score 1) 70
Comment Age Verification is a Win Win for AI Services (Score 1) 54
Meanwhile, OpenAI has no public posting capability and is not required to authenticate users age. It also is mostly pay-for-play and one of the top users of AI are kids under 18,.
So, either Google/Meta socials validate users - which wont happen - and users gravitate to AI for 'time spent'. It's a win-win for AI services.